GCL
RVPHW

Glazer Capital LLC’s Reviva Pharmaceuticals Warrants RVPHW Stock Holding History

Glazer Capital LLC’s Portfolio RVPHW Stock Details RVPHW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-480,459
Closed -$244K – 976
2021
Q2 		$244K Sell
480,459
-209,707
-30% -$94.4K ﹤0.01% 716
2021
Q1 		$317K Hold
690,166
– – ﹤0.01% 625
2020
Q4 		$466K Sell
690,166
-24,850
-3% -$13.6K 0.02% 297
2020
Q3 		$365K Sell
715,016
-18,310
-2% -$8.16K 0.02% 211
2020
Q2 		$345K Buy
733,326
+444,300
+154% +$104K 0.02% 137
2020
Q1 		$26K Hold
289,026
– – ﹤0.01% 178
2019
Q4 		$26K Sell
289,026
-1,000
-0.3% -$229 ﹤0.01% 156
2019
Q3 		$72K Sell
290,026
-1,000
-0.3% -$192 0.01% 145
2019
Q2 		$58K Hold
291,026
– – 0.01% 139
2019
Q1 		$47K Buy
291,026
+41,026
+16% +$8.13K 0.01% 125
2018
Q4 		$83K Buy
+250,000
New +$80.2K 0.01% 121

Other funds holding RVPHW

BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
ASM
ATW SPAC Management New York $79.2M AUM 10.67% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Glazer Capital LLC's RVPHW Position: Q3 2021 in Review

Glazer Capital LLC sold out of Reviva Pharmaceuticals Warrants (RVPHW) in Q3 2021, closing a stake of 480,459 shares — an estimated $244K sold.

Glazer Capital LLC first reported a position in RVPHW in Q4 2018 and held it in 11 quarters. The position peaked at $466K in Q4 2020. 8 funds tracked by Wall St. Rank hold RVPHW as of Q3 2021.

  • Glazer Capital LLC reported no remaining Reviva Pharmaceuticals Warrants position as of Q3 2021 after selling out during the quarter.
  • Glazer Capital LLC sold 480,459 Reviva Pharmaceuticals Warrants shares in Q3 2021, an estimated $244K.
  • Glazer Capital LLC first reported a position in Reviva Pharmaceuticals Warrants in Q4 2018 and held it in 11 quarters.
  • Glazer Capital LLC's Reviva Pharmaceuticals Warrants position peaked at $466K in Q4 2020.
  • 8 funds tracked by Wall St. Rank held Reviva Pharmaceuticals Warrants as of Q3 2021.

Based on Glazer Capital LLC's 13F filing for Q3 2021, filed 15 Nov 2021.